The World Health Organization (WHO) announced that it has reached a royalty-free agreement on Covid-19 antibody detection technology, which will be shared with low- and middle-income countries.
The World Health Organization (WHO) announced on November 23 that the Spanish National Institute (CSIC) has agreed to share free antibody testing technology with low- and middle-income countries. According to Reuters.
This technology will help test the presence of antibodies in people who have been vaccinated or recovered from Covid-19 infection. In addition, the test kit helps to provide more information to decide whether to accept the booster vaccine.
It is said that the kit is easy to use and suitable for rural health institutions with basically complete facilities.
This non-exclusive license agreement allows the technology to be provided as a global public product for the benefit of producing and commercializing countries.
Low-income and middle-income countries do not need to pay patent royalties, and the license will remain valid until the patent expires.
This is the first testing technology sharing license signed by the WHO Pharmaceutical Patent Office (MPP).
WHO Director-General Tedros Adhanom Ghebreyesus welcomes the agreement and hopes that it will inspire others to share technologies in vaccines, treatments and diagnostic tools to combat the Covid-19 pandemic.
